Imperial College Spinout Biocentis Raises $19 Million to Advance Genome-Engineered Insect Control Technology
核心洞察
Biocentis (搜索), an Imperial College London spinout, has secured $19 million in funding to develop genome-engineered insects with reduced fertility that can control harmful wild populations without environmental damage.
The company's first targets include mosquitoes that transmit dengue fever (搜索), Zika (搜索), yellow fever (搜索) and chikungunya (搜索), as well as invasive fruit flies threatening global fruit production.
The funding will enable field trials across the US, Brazil and other key markets, while the company leverages artificial intelligence to simulate biological system performance in real-world environments.
Biocentis (搜索), a spinout from Imperial College London, has raised $19 million to advance its genome engineering platform that develops insects with genetic traits to reduce fertility in target species. The funding comprises $13 million in seed equity investment led by The Grantham Foundation for the Protection of the Environment (搜索) and Algebris Investments (搜索), plus a $6 million award from Wellcome (搜索).
The company's innovative approach addresses critical global health and agricultural challenges by targeting specific harmful insect populations. Its first applications focus on mosquitoes responsible for transmitting dengue fever (搜索), Zika (搜索), yellow fever (搜索) and chikungunya (搜索), as well as highly invasive fruit flies that threaten global fruit production.
Precision Genome Engineering Technology
Biocentis (搜索) uses proprietary genome engineering techniques to develop insects with reduced fertility within target species. When these modified insects are released into the wild, they mate with natural populations, reducing their size while leaving other species and the environment unharmed.
"Genome engineering now allows us to manage harmful insect populations with a level of precision that simply wasn't possible before," said Dr Andrew Hammond, co-founder and Chief Scientific Officer at Biocentis (搜索). "By embedding carefully designed genetic traits within targeted harmful pest species, we can reduce their capacity to cause harm while preserving the integrity of surrounding ecosystems."
The approach represents a sustainable alternative to pesticides, as it does not use toxic substances that could harm humans or other species. The modified insects instinctively seek out and mate with others of their own species, ensuring precision and high efficacy in population control.
AI-Powered Simulation Platform
Beyond genome engineering, Biocentis (搜索) leverages artificial intelligence to build digital twins that simulate how biological systems perform in real-world environments. This computational approach accelerates development and helps decision-makers anticipate emerging insect-borne risks.
"Our software allows us to predict outcomes and build confidence among stakeholders, helping them foresee and manage future challenges," said Giorgio Rocca, co-founder and Chief Executive of Biocentis (搜索).
Field Trial Expansion
The $19 million funding will enable Biocentis (搜索) to advance its first solutions into field trials across the US, Brazil, and other key markets. The company will also expand its technology platform to new applications, targeting insects that carry disease, destroy crops, or threaten ecosystems by driving out native species.
Formed in 2022 by Imperial researchers in partnership with venture creation experts, Biocentis (搜索) aims to create more effective and sustainable methods of insect control. The seed investment round included participation from Neurone, Corbites, Novaterra and a network of entrepreneurs, including founders of two European tech unicorns.
"Our approach combines exceptional effectiveness with true sustainability," Rocca noted. "It's a smarter, safer, and integrated approach to tackle some of the world's toughest challenges."